arrow
M

Mathilde Hunault

CHU d'Angers
H指数:42
被引数:6,913

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Thrombosis in individuals with high oxygen affinity hemoglobin-associated erythrocytosis: A systematic review and analysis of a national cohort

高氧亲和力血红蛋白相关红细胞增多症个体的血栓形成:一项基于国家队列的系统性综述与分析

2026-09-100
OAAI
Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia

在急性髓系白血病强化诱导化疗期间,经肠内与经肠外营养支持的营养结局比较

2026-08-180
PRE
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis

非侵入性多参数表征原发性血小板增多症、骨髓纤维化前期和显性骨髓纤维化

Leukemia
IF13.4
2026-08-030
OA
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy

年轻急性髓系白血病患者接受强化化疗治疗后FLT3-ITD微克隆的预后影响

Blood
IF23.1
2026-05-250
PRE
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement

NUP98重排的成人急性髓系白血病患者的综合突变谱和临床结局

Leukemia
IF13.4
2026-05-120
PRE
Blinatumomab consolidation for high-risk Ph-negative B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study

Blinatumomab巩固治疗高风险Ph阴性B细胞急性淋巴细胞白血病:GRAALL-2014/B-QUEST研究

Blood
IF23.1
2026-04-280
PRE
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Association Between Molecular Profile and Outcome After Intensive Chemotherapy in Patients > 60 Years With Secondary and/or Adverse Cytogenetics Acute Myeloid Leukemia—A FILO Study

> 60岁具有次发和/或不良核型急性髓系白血病患者在强化化疗后的分子特征与预后的关联性——一项FILO研究

2025-09-120
OAAI
Clusterin and pentraxin 3 are markers of severity during febrile neutropenia in adults with haematological malignancies receiving intensive chemotherapy

Clusterin和pentraxin 3是接受强化疗的血液系统恶性肿瘤成人患者发热性中性粒细胞减少症严重程度的标志物。

2025-07-280
OAAI
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia

高危及急性早幼粒细胞白血病患者真实世界队列中三氧化二砷诱导治疗与化疗的比较

Leukemia
IF13.4
2025-06-240
PRE
Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38-LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network

流式微小残留病(MRD)监测结合Laip/Dfn和CD34\^+CD38^-LSCs是独立于ELN-2022风险的成人急性髓系白血病(AML)结局的强预测因子:法国多中心急性白血病间组MRD流式网络的初步结果

BLOOD
IF23.1
2024-11-050
PRE
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study
LEUKEMIA
IF13.4
2024-07-171
OAAI
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
2023-11-270
OA
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosis
2023-05-0110
PREAI
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
LEUKEMIA
IF13.4
2023-04-2111
OAAI
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center study
2023-04-118
PRE
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores
2023-04-053
OA
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study
2023-03-092
OAAI